Restoring Dystrophin in Mice with Duchenne Muscular Dystrophy

Researchers at Tevard Biosciences developed a suppressor tRNA therapy that successfully restored full-length dystrophin proteins in mice models of Duchenne muscular dystrophy, offering hope for treating cases caused by nonsense mutations.